Advertisement

Sex hormones, appetite and eating behaviour in women

      Abstract

      Sex hormones play essential roles in the regulation of appetite, eating behaviour and energy metabolism and have been implicated in several major clinical disorders in women. Estrogen inhibits food intake, whereas progesterone and testosterone may stimulate appetite. This review describes recent findings concerning interactions between sex hormones and neuroendocrinological mechanisms in the control of appetite and eating in women. Furthermore, we are gaining insights into the roles played by sex hormones in the development of eating disorders and obesity. For instance, androgens may promote bulimia by stimulating appetite and reducing impulse control, a proposal supported by the observation that antiandrogenic treatment attenuates bulimic behaviour. Androgens are also involved in the pathophysiology of abdominal obesity in women. On the other hand, hormone replacement therapy with estrogen counteracts the weight gain and accumulation of abdominal fat associated with the menopausal transition. In conclusion, sex hormones and/or agents that exhibit similar activities may provide novel strategies for the treatment of eating disorders and android obesity, two of the most serious health problems for women today.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hirschberg A.L.
        Appetite.
        in: Becker K.L. Principles and practice of endocrinology and metabolism. 3rd edn. Lippencott Company, Philadelphia2001: 1233-1239
        • Woods S.C.
        • D’Alessio D.A.
        Central control of body weight and appetite.
        J Clin Endocrinol Metab. 2008; 93: 537-550
        • Suzuki K.
        • Simpson K.A.
        • Minnion J.S.
        • Shillito J.C.
        • Bloom S.R.
        The role of gut hormones and the hypothalamus in appetite regulation.
        Endocr J. 2010; 57: 359-372
        • Gibson C.D.
        • Carnell S.
        • Ochner C.N.
        • Geliebter A.
        Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.
        J Neuroendocrionol. 2010; 22: 833-845
        • Nakazato M.
        • Murakami N.
        • Date Y.
        • et al.
        A role for ghrelin in the central regulation of feeding.
        Nature. 2001; 409: 194-198
        • Friedman J.M.
        • Halaas J.L.
        Leptin and the regulation of body weight in mammals.
        Nature. 1998; 395: 763-770
        • Dardeno T.A.
        • Chou S.H.
        • Moon H.S.
        • Chamberland J.P.
        • Fiorenza C.G.
        • Mantzoros C.S.
        Leptin in human physiology and therapeutics.
        Front Neuroendocrinol. 2010; 31: 377-393
        • Munzberg H.
        Leptin-signaling pathways and leptin resistance.
        Forum Nutr. 2010; 63: 123-132
        • Air E.L.
        • Benoi S.C.
        • Blake Smith K.A.
        • Clegg D.J.
        • Woods S.C.
        Acute third ventricular administration of insulin decreases food intake in two paradigms.
        Pharmacol Biochem Behav. 2002; 72: 423-429
        • Asarian L.
        • Geary N.
        Modulation of appetite by gonadal steroid hormones.
        Phil Trans R Soc B. 2006; 361: 1251-1263
        • Butera P.C.
        Estradiol and the control of food intake.
        Physiol Behav. 2010; 99: 175-180
        • Liang Y.Q.
        • Akishita M.
        • Kim S.
        • et al.
        Estrogen receptor β is involved in the anorectic action of estrogen.
        Int J Obes. 2002; 26: 1103-1109
        • Santollo J.
        • Katzenellenbogen B.S.
        • Katzenellenbogen J.A.
        • Eckel L.A.
        Activation of ERα is necessary for estradiol's anorexigenic effect in female rats.
        Horm Behav. 2010; 58: 872-877
        • Lindén A.
        • Uvnäs-Moberg K.
        • Forsberg G.
        • Bednar I.
        • Södersten P.
        Involvement of cholecystokinin in food intake: III. Oestradiol potentiates the inhibitory effect of cholecystokinin octapeptide on food intake in ovariectomized rats.
        J Neuroendocrinol. 1990; 2: 797-801
        • Geary N.
        Estradiol, CCK and satiation.
        Peptides. 2001; 22: 1251-1263
        • Clegg D.J.
        • Brown L.M.
        • Zigman J.M.
        • et al.
        Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats.
        Diabetes. 2007; 56: 1051-1058
        • Sotonyi P.
        • Gao Q.
        • Bechmann I.
        • Horvath T.L.
        Estrogen promotes parvalbumin expression in arcuate nucleus POMC neurons.
        Reprod Sci. 2010; 17: 1077-1080
        • Olofsson L.E.
        • Pierce A.A.
        • Xu A.W.
        Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake.
        Proc Nat Acad Sci USA. 2009; 106: 15932-15937
        • Wade G.N.
        • Schneider J.E.
        Metabolic fuels and reproduction in female mammals.
        Neurosci Biobehav Rev. 1992; 16: 235-272
        • Chai J.K.
        • Blaha V.
        • Meguid M.M.
        • Laviano A.
        • Yang Z.J.
        • Varma M.
        Use of orchiectomy and testosterone replacement to explore meal number-to-meal size relationship in male rats.
        Am J Physiol. 1999; 276: R1366-R1373
        • Nohara K.
        • Zhang Y.
        • Waraich R.S.
        • et al.
        Early-life exposure to testosterone programs the hypothalamic melanocortin system.
        Endocrinology. 2011; 152: 1661-1669
        • Schneider J.E.
        Metabolic and hormonal control of the desire for food and sex: implications for obesity and eating disorders.
        Horm Behav. 2006; 50: 562-571
        • Buffenstein R.
        • Poppitt S.D.
        • McDevitt R.M.
        • Prentice A.M.
        Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research.
        Physiol & Behav. 1995; 58: 1067-1077
        • Dye L.
        • Blundell J.E.
        Menstrual cycle and appetite control: implications for weight regulation.
        Hum Reprod. 1997; 12: 1142-1151
        • Cross G.B.
        • Marley J.
        • Miles H.
        • Willson K.
        Changes in nutrient intake during the menstrual cycle of overweight women with premenstrual syndrome.
        Br J Nutr. 2001; 85: 475-482
        • Bryant M.
        • Truesdale K.P.
        • Dye L.
        Modest changes in dietary intake across the menstrual cycle: implications for food intake research.
        Br J Nutr. 2006; 96: 888-894
        • Reed S.C.
        • Levin F.R.
        • Evans S.M.
        Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
        Horm Behav. 2008; 54: 185-193
        • Brennan I.M.
        • Feltrin K.L.
        • Nair N.S.
        • et al.
        Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women.
        Am J Physiol Gastrointest Liver Physiol. 2009; 297: G602-G610
        • Klump K.L.
        • Keel P.K.
        • Culbert K.M.
        • Edler C.
        Ovarian hormones and binge eating: exploring associations in community samples.
        Psychol Med. 2008; 38: 1749-1757
        • Webb P.
        24-hour energy expenditure and the menstrual cycle.
        Am J Clin Nutr. 1986; 44: 614-619
        • Tarasuk V.
        • Beaton G.H.
        Menstrual-cycle patterns in energy and macronutrient intake.
        Am J Clin Nutr. 1991; 53: 442-447
        • Wing R.R.
        • Matthews K.A.
        • Kuller L.H.
        • Meilahn E.N.
        • Plantinga P.L.
        Weight gain at the time of menopause.
        Arch Intern Med. 1991; 151: 97-102
        • Lovejoy J.C.
        • Champagne C.M.
        • de Jonge L.
        • Xie H.
        • Smith S.R.
        Increased visceral fat and decreased energy expenditure during the menopausal transition.
        Int J Obes. 2008; 32: 949-958
        • Reimer R.A.
        • Debert C.T.
        • House J.L.
        • Poulin M.J.
        Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy.
        Physiol Behav. 2005; 84: 303-312
        • Rebuffe-Scrive M.
        • Eldh J.
        • Hafström L.O.
        • Björntorp P.
        Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause.
        Metabolism. 1986; 35: 792-797
        • Hirschberg A.L.
        Hormonal regulation of appetite and food intake.
        Ann Med. 1998; 30: 7-20
        • Brunton P.J.
        • John A.
        • Russell J.A.
        Endocrine induced changes in brain function during pregnancy.
        Brain Res. 2010; 1364: 198-215
        • Frick G.
        • Bremme K.
        • Sjögren C.
        • Lindén A.
        • Uvnäs-Moberg K.
        Plasma levels of cholecystokinin and gastrin during the menstrual cycle and pregnancy.
        Acta Obstet Gynecol Scand. 1990; 69: 317-320
        • Tham E.
        • Liu J.
        • Innis S.
        • et al.
        Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: relationship with cholinesterase.
        Am J Physiol Endocrinol Metab. 2009; 296: E1093-E1100
        • Butte N.F.
        • Hopkinson J.M.
        • Nicolson M.A.
        Leptin in human reproduction: serum leptin levels in pregnant and lactating women.
        J Clin Endocrinol Metab. 1997; 82: 585-589
        • Lindberg U.-B.
        • Leibel R.L.
        • Silfverstolpe G.
        • Hirsch J.
        • Björntorp P.
        • Rébuffé-Scrive M.
        Effects of early pregnancy on regional adipose tissue metabolism.
        Horm Metab Res. 1991; 23: 25-29
        • Lederman S.A.
        Influence of lactation on body weight regulation.
        Nutr Rev. 2004; 62: S112-S119
        • Lindén A.
        • Uvnäs-Moberg K.
        • Forsberg G.
        • Bednar I.
        • Eneroth P.
        • Södersten P.
        Involvement of cholecystokinin in food intake. II. Lactational hyperphagia in the rat.
        J Neuroendocrinol. 1990; 2: 791-796
        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders.
        4th edn. American Psychiatric Press, Washington, DC1994
        • Chan J.L.
        • Mantzoros C.S.
        Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa.
        Lancet. 2005; 366: 74-85
        • Versini A.
        • Ramoz N.
        • Le Strat Y.
        • et al.
        Estrogen receptor 1 Gene (ESR1) is associated with restrictive anorexia nervosa.
        Neuropsychopharmacol. 2010; 35: 1818-1825
        • Kaye W.
        Neurobiology of anorexia and bulimia nervosa purdue ingestive behavior research center symposium influences on eating and body weight over the lifespan: children and adolescents.
        Physiol Behav. 2008; 94: 121-135
        • Crow S.J.
        • Thuras P.
        • Keel P.K.
        • Mitchell J.E.
        Long-term menstrual and reproductive function in patients with bulimia nervosa.
        Am J Psychiatr. 2002; 159: 1048-1050
        • Morgan J.F.
        • McCluskey S.E.
        • Brunton J.N.
        • Lacey J.H.
        Polycystic ovarian morphology and bulimia nervosa: a 9-year follow-up study.
        Fertil Steril. 2002; 77: 928-931
        • Naessén S.
        • Garoff L.
        • Carlström K.
        • Glant R.
        • Hirschberg A.L.
        Polycystic ovary syndrome in bulimic women – an evaluation based on the new diagnostic criteria.
        Gynecol Endocrinol. 2006; 22: 388-394
        • Ehrmann D.A.
        Polycystic ovary syndrome.
        N Engl J Med. 2005; 352: 1223-1236
        • Hirschberg A.L.
        • Naessén S.
        • Stridsberg M.
        • Byström B.
        • Holte J.
        Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome.
        Gynecol Endocrinol. 2004; 19: 79-87
        • Moran L.
        • Norman R.J.
        Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
        Best Pract Res Clin Obstet Gynaecol. 2004; 18: 719-736
        • Lim S.S.
        • Norman R.J.
        • Clifton P.M.
        • Noakes M.
        Hyperandrogenemia, psychological distress, and food cravings in young women.
        Physiol Behav. 2009; 98: 276-280
        • Emmen J.M.A.
        • Korach K.S.
        Estrogen receptor knockout mice: phenotypes in the female reproductive tract.
        Gynecol Endocrinol. 2003; 17: 169-176
        • Nilsson M.
        • Naessén S.
        • Dahlman I.
        • Hirschberg A.L.
        • Gustafsson J.-Å.
        • Dahlman-Wreight K.
        Association of estrogen receptor ß gene polymorphisms with bulimic disease in women.
        Mol Psychiatry. 2004; 9: 28-34
        • Eriksson E.
        Behavioral effects of androgens in women.
        in: Steiner M. Yonkers K.A. Eriksson E. Mood disorders in women. Martin Dunitz, London2000: 233-246
        • Sundblad C.
        • Landén M.
        • Eriksson T.
        • Bergman L.
        • Eriksson E.
        Effects of the androgen antagonist flutamide and the serotonin reuptake inhibitor citalopram in bulimia nervosa: a placebo-controlled pilot study.
        J Clin Psychopharmacol. 2005; 25: 85-88
        • Naessén S.
        • Carlström K.
        • Byström B.
        • Pierre Y.
        • Hirschberg A.L.
        Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.
        Psychoneuroendocrinology. 2007; 32: 548-554
        • Barsh G.S.
        • Farooqi L.S.
        • O’Rahilly S.
        Genetics of body-weight regulation.
        Nature. 2000; 404: 644-651
        • Farooqi L.S.
        Genetic, molecular and physiological insights into human obesity.
        Eur J Clin Invest. 2011; 41: 451-455
        • Gibson C.D.
        • Carnell S.
        • Ochner C.N.
        • Geliebter A.
        Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.
        J Neuroendocrinol. 2010; 22: 833-845
        • Pasquali R.
        • Vicennati V.
        • Gambineri A.
        • Pagotto U.
        Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.
        Int J Obes. 2008; 32: 1764-1779
        • Torres S.J.
        • Nowson C.A.
        Relationship between stress, eating behavior and obesity.
        Nutrition. 2007; 23: 887-894
        • Hirschberg A.L.
        Polycystic ovary syndrome, obesity and reproductive implications.
        Women's Health. 2009; 5: 529-542
        • Westhoff C.L.
        • Heartwell S.
        • Edwards S.
        • et al.
        Oral contraceptive discontinuation: do side effects matter?.
        Am J Obstet Gynecol. 2007; 196 (e1–e7): 412
        • Wysocki S.
        A survey of America women regarding the use of oral contraceptives and weight gain.
        Int J Gynecol Obstet. 2000; 70: 114
        • Gallo M.F.
        • Lopez L.M.
        • Grimes D.A.
        • Schulz K.F.
        • Helmerhorst F.M.
        Combination contraceptives: effects on weight.
        Cochrane Database Syst Rev. 2008; : CD003987
        • Lindh I.
        • Ellström A.A.
        • Milsom I.
        The long-term influence of combined oral contraceptives on body weight.
        Hum Reprod. 2011; 26: 1917-1924
        • Lidegaard O.
        • Nielsen L.H.
        • Skovlund C.W.
        • Skjeldestad F.E.
        • Løkkegaard E.
        Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish Cohort Study, 2001–2009.
        Br Med J. 2011; 343: d6423
        • Kurshan N.
        • Epperson C.N.
        Oral contraceptives and mood in women with and without premenstrual dysphoria: a theroretical model.
        Arch Womens Ment Health. 2006; 9: 1-14
        • Maltoni M.
        • Nanni O.
        • Scarpi E.
        • Rossi D.
        • Serra P.
        • Amadori D.
        High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
        Ann Oncol. 2001; 12: 289-300
        • Karlsson R.
        • Lindén A.
        • von Schoultz B.
        Suppression of 24 hour cholecystokinin secretion by oral contraceptives.
        Am J Obstet Gynecol. 1992; 167: 58-59
        • Hirschberg A.L.
        • Byström B.
        • Carlström K.
        • von Schoultz B.
        Reduced serum cholecystokinin and increase in body fat during oral contraception.
        Contraception. 1996; 53: 109-113
        • Sitruk-Ware R.
        New progestagens for contraceptive use.
        Hum Reprod Update. 2006; 12: 169-178
        • Santen R.J.
        • Allred D.C.
        • Ardoin S.P.
        • et al.
        Postmenopausal hormone therapy: an Endocrine Society scientific statement.
        J Clin Endocrinol Metab. 2010; 95: 1-66
        • Reubinoff B.E.
        • Wurtman J.
        • Rojansky N.
        • et al.
        Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study.
        Fertil Steril. 1995; 64: 963-968
        • Reimer R.A.
        • Debert C.T.
        • House J.L.
        • Poulin M.J.
        Dietary and metabolic differences in pre- versus postmoenopaousal women taking or not taking hormone replacement therapy.
        Physiol Behav. 2005; 84: 303-312
        • Norman R.J.
        • Flight I.H.
        • Rees M.C.
        Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
        Cochrane Database Syst Rev. 2000; : CD001018
        • Kristensen K.
        • Pedersen S.B.
        • Vestergaard P.
        • Mosekilde L.
        • Richelsen B.
        Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women.
        J Endocrinol. 1999; 163: 55-62
        • Gambacciani M.
        • Ciaponi M.
        • Cappagli B.
        • Simone L.
        • Orlandi R.
        • Genazzani A.R.
        Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy.
        Maturitas. 2001; 39: 125-132
        • Sumino H.
        • Ichikawa S.
        • Yoshida A.
        • et al.
        Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women.
        Int J Obes Relat Metab Disord. 2003; 27: 1044-1051
        • Chen Z.
        • Bassford T.
        • Green S.B.
        • et al.
        Postmenopausal hormone therapy and body composition – a substudy of the estrogen plus progestin trial of the Women's Health Initiative.
        Am J Clin Nutr. 2005; 82: 651-656
        • Lindberg U.B.
        • Crona N.
        • Silfverstolpe G.
        • Björntorp P.
        • Rebuffé-Scrive M.
        Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids.
        Horm Metab Res. 1990; 22: 345-351
        • O'Sullivan A.J.
        • Crampton L.J.
        • Freund J.
        • Ho K.K.
        The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
        J Clin Invest. 1998; 102: 1035-1040
        • Mathur R.
        • Braunstein G.D.
        Androgen deficiency and therapy in women.
        Curr Opin Endocrinol Diabetes Obes. 2010; 17: 342-349
        • Zang H.
        • Carlström K.
        • Arner P.
        • Hirschberg A.L.
        Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
        Fertil Steril. 2006; 86: 136-144
        • Zang H.
        • Rydén M.
        • Wåhlen K.
        • Dahlman-Wrigth K.
        • Arner P.
        • Hirschberg A.L.
        Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women.
        Fertil Steril. 2007; 88: 100-106